This was meant to be a week of great optimism and promise. Late on Friday Bury FC were given a reprieve from being thrown out of the football league, and there was enthusiasm on the OPTI:Optibiotix forums about the impending H1 results and the next stage in our march towards profitability.
This morning all that hope lay in ruin.
Late last night the EFL expelled Bury from the football league.
Early this morning underwhelming H1 results caused a 30% crash in the OPTI:Optibiotix share price.
Yeah thanks. Kick a man when he's down!!
I sat shell shocked as my football team vanished from the league and my portfolio value plummeted by over £18,000.
I was in a daze most of the morning.
There's only one thing I know how to do when I'm on the floor and battered. That's get back up and fight to the bitter end.
I've held AMYT:Amryt Pharma for many years, since they were FAST:Fastnet Equity. I sold a chunk a few years ago for £392.17 (6.5%) profit, but kept 1,385 shares. They have been suspended for months as they looked into a reverse takeover of Aegerion Pharmaceuticals. They re-listed yesterday, but to my horror I read that Harry Stratford was standing down as Chairman. The main reason I invested in the first place was for his experience on the board. I am also concerned that they are taking over a loss-making company, especially as I've been bitten by some disastrous junior pharma shares lately, with MTFB:Motif Bio and N4P:N4 Pharma losing me thousands with limited hope of recovery.
The news in the RNS set so many red flags waving I had to get out. Fortunately the share price had risen on re-listing and my loss was relatively small. I sold my shares at 100p after paying 111.2152p, so ended up with a £167.28 (10.8%) loss. This meant I still ended up with over £200 profit from my overall holding, but that's a very small percentage gain.
There's no need to ask what I did with the cash. I wasn't going to see OPTI:Optibiotix go below 50p and not do anything about it. I bought 2,937 shares at 46.7998p costing £1,386.46. The timing was good, as they ended the day on a bid price of 53p so have already made up most of the £167 loss I took this morning to get the cash, as the new OPTI shares are up by £146. I firmly believe these have a much greater chance of success than my AMYT shares would have.
This is part of my plan to get up to 100,000 shares in OPTI, and I'm not far off. This purchase takes my holding to 97,023 so every penny change in share price is worth £970. Eeeek!
Unfortunately the 12p drop prior to buying these shares cost me £11,280. It could have been worse. At one point I was losing nearly £19,000 in a few hours of the market opening.
So where are we after this day of traumatic events?
The combined portfolios have dive-bombed by £11,654 widening the deficit over cost and value to £31,927 and reducing the portfolio value to just £72,463. That's barely above the cash injection line and did cross it at one point during the morning. Fortunately I have 2 days before my snapshot, so there's hope that people will realise just how mad the drop in share price was today, and pile back in. I've never needed a good news story as much as I need one this week.
Meanwhile, regarding my other source of trauma, rumours are circulating that an international consortium has £7 million to buy Bury FC. It's too bloody late to come up with that now! They are appealing for the EFL to rescind the expulsion, but surely it's too little too late? There is a spark of hope. It's maybe just a fool's hope, but that worked for Frodo...
Wednesday 28 August 2019
Saturday 24 August 2019
Week 211 Review - Last week's losses nearly clawed back
Last week my portfolio value dropped by £4,967 and this week it increased by £4,888 so most of the damage has been fixed, but the deficit is still £20,273 and the total value well below the £104K cost at £84,271.
Worst performer was N4P:N4 Pharma which I have very little hope for. I'll keep them because they are down 87% so it's not really worth selling, but the chances of them getting anywhere on their one remaining product remain slim.
TLOU:Tlou Energy dropped 5% to go 50% down, which is a real mystery in the week they announced they have continuous gas flow. I was expecting a re-rate upwards not a drop!
TRMR:Tremor continued it's volatility, climbing 6% but it is still 45% down. I think unfairly but I would say that. I'm confident I'll get some profit from these, but given it's in my trading account, it's a bit of a disaster.
Share of the Week is good old OPTI:Optibiotix which climbed 8% and is only 1% down. In fact my share account holding is just in profit. A new study has proved Sweetbiotix to be 100% fibre, which I think is massive news for companies worldwide who want to increase fibre and reduce sugar.
Let's hope this is a continuing climb.
Still a long way to go to get above the trend line, and even longer to pull it flat again.
The ISA and share accounts look like this
The gains in this account actually beat last week's losses, and were mostly thanks to OPTI:Optibiotix, which was also responsible for the return to having some potential profit, albeit only £11. Given the market, I'm happy with 9.2% average performance, but really need to get back in the black on the portfolio.
Thank goodness it didn't reach the injection line as that would be a disaster.
As with the combined portfolios, still below the trend line and a sorry 12 month picture.
The SIPP looks like this after week 195
This account didn't manage to recover all last week's losses. I'm not happy with the 8% average performance but there's no sign I'll be able to improve it any time soon.
Nice to be nearer the red line than the orange.
Really horrible steep drop of £10K over just 6 weeks. I hope the recovery is equally steep.
The trading account looks like this after week 161
A slight improvement thanks to small recoveries in CAML:Central Asia Metals and TRMR:Tremor, but the nearest share to making a profit is CAML which is 27% down.
It's above the trend line!
Here's my performance in the This Is Money fantasy game
A bad week, dropping 231 places from 560th to 791st. I'm not really sure of the rules. If I flog the rubbish shares, does that mean I bank the loss or just lose the poor statistic. I think I need to check. I don't see how it could work if I sold LLOY:Lloyds to get it off my portfolio and then bought it back I don't see how that would work.
Not surprising it's just gold doing well.
That's it - Bank Holiday weekend and it's sunny so I'm not spending any more time writing this.
Worst performer was N4P:N4 Pharma which I have very little hope for. I'll keep them because they are down 87% so it's not really worth selling, but the chances of them getting anywhere on their one remaining product remain slim.
TLOU:Tlou Energy dropped 5% to go 50% down, which is a real mystery in the week they announced they have continuous gas flow. I was expecting a re-rate upwards not a drop!
TRMR:Tremor continued it's volatility, climbing 6% but it is still 45% down. I think unfairly but I would say that. I'm confident I'll get some profit from these, but given it's in my trading account, it's a bit of a disaster.
Share of the Week is good old OPTI:Optibiotix which climbed 8% and is only 1% down. In fact my share account holding is just in profit. A new study has proved Sweetbiotix to be 100% fibre, which I think is massive news for companies worldwide who want to increase fibre and reduce sugar.
Let's hope this is a continuing climb.
Still a long way to go to get above the trend line, and even longer to pull it flat again.
The ISA and share accounts look like this
| Weekly Change | |||
| Cash | £23.52 | +£0 | |
| Portfolio cost | £57,992.82 | +£0 | |
| Portfolio sell value (bid price-commission) | £45,186.12 | (-22%) | +£2,707.33 |
| Potential profits | £11.66 | +£11.66 | |
| Yr 5 Dividends | £0 | +£0 | |
| Yr 5 Profit from sales | £0 | +£0 | |
| Yr 5 Average monthly cash profit | £0 | (0%) | +£0 |
| Total Dividends | £1,342.30 | +£0 | |
| Total Profit from sales | £20,391.41 | +£0 | |
| Average monthly cash profit | £442.41 | (9.2%) | -£2.11 |
| (Sold stocks profit + Dividends - Fees / Months) |
The gains in this account actually beat last week's losses, and were mostly thanks to OPTI:Optibiotix, which was also responsible for the return to having some potential profit, albeit only £11. Given the market, I'm happy with 9.2% average performance, but really need to get back in the black on the portfolio.
Thank goodness it didn't reach the injection line as that would be a disaster.
As with the combined portfolios, still below the trend line and a sorry 12 month picture.
The SIPP looks like this after week 195
| Weekly Change | |||
| Cash | £15.52 | +£0 | |
| Portfolio cost | £44,226.49 | +£0 | |
| Portfolio sell value (bid price - commission) |
£37,712.23 | (-14.7%) | +£2,128.54 |
| Potential profits | £0 | +£0 | |
| Yr 4 Dividends | £361.99 | +£0 | |
| Yr 4 Interest | £0.09 | +£0 | |
| Yr 4 Profit from sales | £1,440.43 | +£0 | |
| Yr 4 Average monthly cash profit | £186.70 | (5.1%) | -£4.92 |
| Total Dividends | £1,704.24 | +£0 | |
| Total Interest | £0.12 | +£0 | |
| Total Profit from sales | £11,985.35 | +£0 | |
| Average monthly cash profit | £295.23 | (8.0%) | -£1.53 |
| (Sold stocks profit + Dividends - Fees / Months) |
This account didn't manage to recover all last week's losses. I'm not happy with the 8% average performance but there's no sign I'll be able to improve it any time soon.
Nice to be nearer the red line than the orange.
Really horrible steep drop of £10K over just 6 weeks. I hope the recovery is equally steep.
The trading account looks like this after week 161
| Weekly Change | |||
| Cash | £35.04 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,299.09 | (-44%) | +£52.02 |
| Potential profits | £0 | +£0 | |
| Year 4 Dividends | £0 | +£0 | |
| Year 4 Profit | £0 | +£0 | |
| Yr 4 Average monthly cash profit | £0 | (0%) | +£0 |
| Dividends | £34.72 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£0.80 | (-0.4%) | +£0 |
| (Sold stocks profit + Dividends - Fees / Months) |
A slight improvement thanks to small recoveries in CAML:Central Asia Metals and TRMR:Tremor, but the nearest share to making a profit is CAML which is 27% down.
It's above the trend line!
Here's my performance in the This Is Money fantasy game
A bad week, dropping 231 places from 560th to 791st. I'm not really sure of the rules. If I flog the rubbish shares, does that mean I bank the loss or just lose the poor statistic. I think I need to check. I don't see how it could work if I sold LLOY:Lloyds to get it off my portfolio and then bought it back I don't see how that would work.
Not surprising it's just gold doing well.
That's it - Bank Holiday weekend and it's sunny so I'm not spending any more time writing this.
Sunday 18 August 2019
Week 210 Review - Just keep piling on the misery
It's taken till Sunday evening for me to be bothered writing anything this week, as sheer misery has taken hold. The combined portfolios were already hammered, but took a £4,967 beating this week to increase the deficit to a whopping £25,161 and drop the portfolio value to £79,383. My best companies are all ridiculously cheap, but I spent all my ammunition a few weeks ago when I had the pension transfer money and the proceeds from selling CEY:Centamin. I acted too early and now all I can do is watch and hope. It's so frustrating that people can rock up and buy companies I've been invested in for years at a lower price than I have paid, possibly just before they start to make real profits. I'm terribly, terribly vexed!
The worst performer was CAML:Central Asia Metals hit by Brexit fears and low metal prices and dropping 8% to go 10% down overall. It shouldn't be, as they showed last time the metal prices were low that they still make lots of profit and the dividend will yield about 10% at this share price. Not only that, they have enough cash to potentially take advantage of these prices to buy out another low cost producer cheap. I'd be filling my boots if I had any spare cash.
SBTX:SkinBioTherapeutics also fell 8% on no news when a deal was expected to be imminent. They are now 22% down and my attempts to trade them have failed miserably.
OPTI:Optibiotix had another dreadful week on hardly any volume despite more good news. There's always good news, and yet the price keeps dropping. I think there's an assumption H1 revenues won't be as high as the market hoped, and people are bailing out anticipating a drop to even lower levels. Many have been stopped out of spread bets too, so fueling the dip. The interesting thing is £500K worth of SBTX shares were sold last week to an institutional investor to raise cash for something - but what? Let's hope it's juicy and lets hope it's this week.
Quite hard to pick Share of the week as the highest risers were only 3%. I'll give it to BLU:Blue Star Capital because it looks like something is going on and there were some massive purchases last week so a flutter of excitement. TRMR:Tremor also climbed 3% but they are ultra volatile so I'm not reading anything into it.
I'm nearer the injection line than the cost line. That's not good.
What a year!
The ISA and share portfolios look like this
Not much to say. Really, really bad.
Dangerously close to the injection line where I would have been better off putting it under the mattress.
Worst ever losses.
The SIPP looks like this after week 194
Exactly the same situation as the ISA. Hit a bit harder because of having both OPTI:Optibiotix and CAML:Central Asia Metals.
A better gap to injection value on this one
This is a much steeper drop though.
The trading account looks like this after week 160
Considering the damage elsewhere, this drop isn't so bad.
A couple of months ago it looked like we were climbing slowly. Not any more.
It's on the trend line - I need a new trend!
Here's the dismal fantasy stock performance
I've only dropped 68 places in the league from 492nd to 560th.
Buying LGEN:Legal & General last week was a really great move. My timing always sucks. Should have just bought gold mines.
I have dim hopes of ever having another good week. I know it will come at some point, and the rebound could be spectacular. At the moment it looks like a distant dream.
The worst performer was CAML:Central Asia Metals hit by Brexit fears and low metal prices and dropping 8% to go 10% down overall. It shouldn't be, as they showed last time the metal prices were low that they still make lots of profit and the dividend will yield about 10% at this share price. Not only that, they have enough cash to potentially take advantage of these prices to buy out another low cost producer cheap. I'd be filling my boots if I had any spare cash.
SBTX:SkinBioTherapeutics also fell 8% on no news when a deal was expected to be imminent. They are now 22% down and my attempts to trade them have failed miserably.
OPTI:Optibiotix had another dreadful week on hardly any volume despite more good news. There's always good news, and yet the price keeps dropping. I think there's an assumption H1 revenues won't be as high as the market hoped, and people are bailing out anticipating a drop to even lower levels. Many have been stopped out of spread bets too, so fueling the dip. The interesting thing is £500K worth of SBTX shares were sold last week to an institutional investor to raise cash for something - but what? Let's hope it's juicy and lets hope it's this week.
Quite hard to pick Share of the week as the highest risers were only 3%. I'll give it to BLU:Blue Star Capital because it looks like something is going on and there were some massive purchases last week so a flutter of excitement. TRMR:Tremor also climbed 3% but they are ultra volatile so I'm not reading anything into it.
I'm nearer the injection line than the cost line. That's not good.
What a year!
The ISA and share portfolios look like this
| Weekly Change | |||
| Cash | £23.52 | +£0 | |
| Portfolio cost | £57,992.82 | +£0 | |
| Portfolio sell value (bid price-commission) | £42,478.79 | (-26.7%) | -£2,447.83 |
| Potential profits | £0 | +£0 | |
| Yr 5 Dividends | £0 | +£0 | |
| Yr 5 Profit from sales | £0 | +£0 | |
| Yr 5 Average monthly cash profit | £0 | (0%) | +£0 |
| Total Dividends | £1,342.30 | +£0 | |
| Total Profit from sales | £20,391.41 | +£0 | |
| Average monthly cash profit | £444.52 | (9.2%) | -£2.13 |
| (Sold stocks profit + Dividends - Fees / Months) |
Not much to say. Really, really bad.
Dangerously close to the injection line where I would have been better off putting it under the mattress.
Worst ever losses.
The SIPP looks like this after week 194
| Weekly Change | |||
| Cash | £15.52 | +£0 | |
| Portfolio cost | £44,226.49 | +£0 | |
| Portfolio sell value (bid price - commission) | £35,583.69 | (-19.5%) | -£2,448.94 |
| Potential profits | £0 | +£0 | |
| Yr 4 Dividends | £361.99 | +£0 | |
| Yr 4 Interest | £0.09 | +£0 | |
| Yr 4 Profit from sales | £1,440.43 | +£0 | |
| Yr 4 Average monthly cash profit | £191.62 | (5.2%) | -£5.18 |
| Total Dividends | £1,704.24 | +£0 | |
| Total Interest | £0.12 | +£0 | |
| Total Profit from sales | £11,985.35 | +£0 | |
| Average monthly cash profit | £296.76 | (8.1%) | -£1.53 |
| (Sold stocks profit + Dividends - Fees / Months) |
Exactly the same situation as the ISA. Hit a bit harder because of having both OPTI:Optibiotix and CAML:Central Asia Metals.
A better gap to injection value on this one
This is a much steeper drop though.
The trading account looks like this after week 160
| Weekly Change | |||
| Cash | £35.04 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,247.07 | (-46.3%) | -£31.09 |
| Potential profits | £0 | +£0 | |
| Year 4 Dividends | £0 | +£0 | |
| Year 4 Profit | £0 | +£0 | |
| Yr 4 Average monthly cash profit | £0 | (0%) | +£0 |
| Dividends | £34.72 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£0.80 | (-0.4%) | +£0.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
Considering the damage elsewhere, this drop isn't so bad.
A couple of months ago it looked like we were climbing slowly. Not any more.
It's on the trend line - I need a new trend!
Here's the dismal fantasy stock performance
I've only dropped 68 places in the league from 492nd to 560th.
Buying LGEN:Legal & General last week was a really great move. My timing always sucks. Should have just bought gold mines.
I have dim hopes of ever having another good week. I know it will come at some point, and the rebound could be spectacular. At the moment it looks like a distant dream.
Saturday 10 August 2019
Week 209 Review - Nearly everything down but we end up flat
Nearly everything ended up down this week. Fortunately the 1p rise in OPTI:Optibiotix limited the damage to a drop of just £27. The deficit is £20,193 and total portfolio value £84,351.
TRMR:Tremor was the worst performer, dropping 11% and wiping out the 10% rise that made it Share of the Week last week when I said "seem to be on the march". They are now beating a hasty retreat.
JLP:Jubilee Metals issued a good solid set of results, so I expected a decent rise. What we got was an 8% drop to make one of my biggest holdings 37% down.
IQE:IQE had another bad week, dropping 6% and damaging all three accounts.
SBTX:SkinBioTherapeutics fell way quicker than I expected, so my cunning plan to trade them on the peaks and troughs has failed miserably as the peak was more of a molehill. Now I'm 14% down and probably have a long wait till they get back in profit.
Share of the Week is very difficult to award as only 4 shares went up, and the biggest rise was 2% in BLU:Blue Star Capital which is one of my smallest holdings so meaningless. TRX:Tissue Regenix climbed 1% and N4P:N4 Pharma climbed less than 1%. That means I have to award Share of the Week to OPTI:Optibiotix, as although they only climbed 1p, that almost single-handedly prevented a loss that would have been around £1,000 this week.
It's now been in the red for four months, and nearer six since it was comfortably in the black.
The ISA and share portfolios look like this
There's no potential profit so at least that can't go down any more! Small drop in value caused by almost everything except OPTI:Optibiotix dropping. The 1p rise in OPTI wasn't enough to rescue the week.
This is the start of year 5, so everything is re-set to zero. It's horrible that the portfolio is down by 22.4% as we start year 5, but the market is in a mess at the moment, and I'm still optimistic about the prospects of many of the companies I'm invested in. An average monthly performance of 9.3% is pretty good to sustain over 4 years, especially as it's based on the cost of the current portfolio.
We need to get August out of the way I think.
Here's the SIPP after week 193
A better performance than the ISA, but it would have been even better if I had delayed selling CEY:Centamin for a week as it went up another 10% while OPTI:Optibiotix is still cheap to buy.
Too sad to say anything about this
The trading account looks like this after week 159
Everything got hammered this week, so no prospect of selling anything for months.
I've tweaked the scale now we've moved past the point where I added £2,000. Fat lot of good that did! I was hoping to have got my £2,000 back by now as the aim was to keep this to 5 shares at £500 and siphon off the profits. What profits?
Amazingly still above the trend line. Joy!
Here's the latest on the fantasy stock game
In a great week I've climbed 371 places from 863rd to 492nd. If only I had left LLOY:Lloyds out of it!
I decided to add LGEN:Legal & General as they've tanked recently and shouldn't have, so they'll appear in my list next week. I feel maybe I should be buying LLOY:Lloyds in my real portfolio at these prices.
So another week without recovery and no shares in profit. I really hope when summer is over things turn around, as this is all rather horrid.
TRMR:Tremor was the worst performer, dropping 11% and wiping out the 10% rise that made it Share of the Week last week when I said "seem to be on the march". They are now beating a hasty retreat.
JLP:Jubilee Metals issued a good solid set of results, so I expected a decent rise. What we got was an 8% drop to make one of my biggest holdings 37% down.
IQE:IQE had another bad week, dropping 6% and damaging all three accounts.
SBTX:SkinBioTherapeutics fell way quicker than I expected, so my cunning plan to trade them on the peaks and troughs has failed miserably as the peak was more of a molehill. Now I'm 14% down and probably have a long wait till they get back in profit.
Share of the Week is very difficult to award as only 4 shares went up, and the biggest rise was 2% in BLU:Blue Star Capital which is one of my smallest holdings so meaningless. TRX:Tissue Regenix climbed 1% and N4P:N4 Pharma climbed less than 1%. That means I have to award Share of the Week to OPTI:Optibiotix, as although they only climbed 1p, that almost single-handedly prevented a loss that would have been around £1,000 this week.
It's now been in the red for four months, and nearer six since it was comfortably in the black.
The ISA and share portfolios look like this
| Weekly Change | |||
| Cash | £23.52 | +£0 | |
| Portfolio cost | £57,992.82 | +£0 | |
| Portfolio sell value (bid price-commission) | £44,926.62 | (-22.4%) | -£101.51 |
| Potential profits | £0 | +£0 | |
| Yr 5 Dividends | £0 | +£0 | |
| Yr 5 Profit from sales | £0 | +£0 | |
| Yr 5 Average monthly cash profit | £0 | (0%) | +£0 |
| Total Dividends | £1,342.30 | +£0 | |
| Total Profit from sales | £20,391.41 | +£0 | |
| Average monthly cash profit | £446.65 | (9.3%) | -£2.22 |
| (Sold stocks profit + Dividends - Fees / Months) |
There's no potential profit so at least that can't go down any more! Small drop in value caused by almost everything except OPTI:Optibiotix dropping. The 1p rise in OPTI wasn't enough to rescue the week.
This is the start of year 5, so everything is re-set to zero. It's horrible that the portfolio is down by 22.4% as we start year 5, but the market is in a mess at the moment, and I'm still optimistic about the prospects of many of the companies I'm invested in. An average monthly performance of 9.3% is pretty good to sustain over 4 years, especially as it's based on the cost of the current portfolio.
We need to get August out of the way I think.
Here's the SIPP after week 193
| Weekly Change | |||
| Cash | £15.52 | +£0 | |
| Portfolio cost | £44,226.49 | +£0 | |
| Portfolio sell value (bid price - commission) | £38,072.63 | (-13.9%) | +£170.48 |
| Potential profits | £0 | +£0 | |
| Yr 4 Dividends | £361.99 | +£0 | |
| Yr 4 Interest | £0.09 | +£0 | |
| Yr 4 Profit from sales | £1,440.43 | +£0 | |
| Yr 4 Average monthly cash profit | £196.80 | (5.3%) | -£5.46 |
| Total Dividends | £1,704.24 | +£0 | |
| Total Interest | £0.12 | +£0 | |
| Total Profit from sales | £11,985.35 | +£0 | |
| Average monthly cash profit | £298.29 | (8.1%) | -£1.56 |
| (Sold stocks profit + Dividends - Fees / Months) |
A better performance than the ISA, but it would have been even better if I had delayed selling CEY:Centamin for a week as it went up another 10% while OPTI:Optibiotix is still cheap to buy.
Too sad to say anything about this
The trading account looks like this after week 159
| Weekly Change | |||
| Cash | £35.04 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,278.16 | (-44.9%) | -£96.24 |
| Potential profits | £0 | +£0 | |
| Year 4 Dividends | £0 | +£0 | |
| Year 4 Profit | £0 | +£0 | |
| Yr 4 Average monthly cash profit | £0 | (0%) | +£0 |
| Dividends | £34.72 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£0.81 | (-0.4%) | +£0 |
| (Sold stocks profit + Dividends - Fees / Months) |
Everything got hammered this week, so no prospect of selling anything for months.
I've tweaked the scale now we've moved past the point where I added £2,000. Fat lot of good that did! I was hoping to have got my £2,000 back by now as the aim was to keep this to 5 shares at £500 and siphon off the profits. What profits?
Amazingly still above the trend line. Joy!
Here's the latest on the fantasy stock game
In a great week I've climbed 371 places from 863rd to 492nd. If only I had left LLOY:Lloyds out of it!
I decided to add LGEN:Legal & General as they've tanked recently and shouldn't have, so they'll appear in my list next week. I feel maybe I should be buying LLOY:Lloyds in my real portfolio at these prices.
So another week without recovery and no shares in profit. I really hope when summer is over things turn around, as this is all rather horrid.
Saturday 3 August 2019
Week 208 Review - It's all gone to hell in a handbag!
Please make it stop! A truly awful week resulting in every single share I own being in the red, even ones that have been in profit for years. I did exacerbate that by selling all my CEY:Centamin holding, which was in profit, but OPTI:Optibiotix and CAML:Central Asia Metals both plunged into the red this week. The result was a £7,154 drop in portfolio value and a widening of the deficit to £20,165 which is the biggest it has ever been, and overall portfolio value of £84,498. That's £35,000 less than its peak just under a year ago, and I've added £15,000 since then.
Worst performer was OPTI:Optibiotix which dropped 10% and now is suffering a 4% loss.This triggered my usual reaction which is to buy more. I sold my entire CEY:Centamin holding despite gold heading upwards to free up capital for the purchase, and also used the majority of my pension transfer which came through this week. The result is my OPTI holding now stands at 94,086 costing £63,417.73. They are losing £3,238.54 after this week's drop. Each penny change in share price is now worth £940. For such a volatile share this is going to be a hell of a roller coaster! My ambition is to get to 100,000 shares now I'm so close. I already own more than 0.1% of the company, which I never thought would happen.
IQE:IQE had a great week last week and I was hoping my ISA holding would get back into profit. However, this week it dropped 6% so the wait continues as they are now 17% down.
JLP:Jubilee Metals may be stirring for a re-rate. They are producing now and ramping up processing capacity, so I feel we're only one announcement away from getting back into profit. The climbed 6% this week but are still stuck on the range between 2.9p and 3.2p and are still 29% down.
Share of the week is TRMR:Tremor in the trading account. They have recently changed their name from TAP:Taptica and seem to be on the march. They climbed 10% this week, but had fallen so far that they are still 43% down.
In real terms this is the worst ever, as I've added so much into the SIPP this year. I'm really hoping patience will be rewarded.
Neil Woodford eat your heart out!
Here's the performance of the ISA and shares portfolios
I sold 1,198 shares in CEY:Centamin and made a tiny £35.10 (2.2%) profit, but with over £50 dividends the total profit was 6%. I used the proceeds to buy 2,312 shares in OPTI:Optibiotix at 67p a share which slightly raises my weighted average to 66.46p, but 67p is pretty much the average across the portfolio so I'm happy to get more at that price.
The sale had virtually no affect on my performance, and as we come to the final week of year 4 I've only achieved 3% on sales and dividends which is way below my 10% target. Under the circumstances, maintaining my long term performance at 9.3% over a 4 year period is pretty impressive, especially as that's based on the current portfolio cost which has increased a lot.
The bad news is the potential profits being completely wiped out to zero, and losses deepening a further £1,400 on top of that. Not a great week!
This is getting dangerously close to my initial cash injection line, which would mean I've made absolutely nothing in 4 years and would have been as well putting the cash in the building society.
The SIPP looks like this after week 192
I sold my 2,965 CEY:Centamin shares for £696.83 (23%) profit, and with the £68 of dividends that was 25%. I used the cash to buy 5,596 OPTI:Optibiotix shares at 66.66p costing £3,742.24. The day before I had my £2,200 pension transfer. I initially bought 393 shares in CAML:Central Asia Metals for 205.67p costing £820.23 which brought my total holding there to 5,000 shares. They are now 9.5% of my portfolio cost and I still consider them to be the best run company I own.
The rest of the transfer was used to buy OPTI:Optibiotix. I purchased 2,070 shares at 69.44p costing £1,449.36. My weighted average price in the SIPP is now 67.97p.
All potential profits were wiped out with the sale and OPTI crash, and losses deepened by an additional £2,000. The sale almost doubled my year 4 performance to 5.5%, but although my long term average improved by £13 a month, the cost of the portfolio rose enough for my percentage performance to drop from 8.3% to 8.1%. I sometimes think my rules are too strict!
Not familiar territory for this account.
I seem to have dropped off a cliff!
The trading portfolio looks like this after week 158
The improvement in TRMR:Tremor mitigated the losses everywhere else so the drop was only £22.
Tootling along rubbishly
Still slowly dragging the trend line upwards
Here's the fantasy stock performance
I only dropped 25 places to 863rd so it could have been much worse.
CEY:Centamin doing very nicely so I'll keep the fantasy version. LLOY:Lloyds rather messing things up. I was hoping the end of PPI would cause a re-rate for the banks, but there are a few stngs in the PPI tail yet so I may have jumped too soon.
A week to forget for share prices, but a week of great excitement as I build my position in OPTI:Optibiotix. I'm still as certain as ever that this is a superb company with astonishing potential. It's brexit-proof and on the cusp of some staggering global deals. The share price was lower than this a year ago, and hit 130p within a few weeks. The rise from here to 130p would be worth £62,000 with my current holding. Bring it on!
Worst performer was OPTI:Optibiotix which dropped 10% and now is suffering a 4% loss.This triggered my usual reaction which is to buy more. I sold my entire CEY:Centamin holding despite gold heading upwards to free up capital for the purchase, and also used the majority of my pension transfer which came through this week. The result is my OPTI holding now stands at 94,086 costing £63,417.73. They are losing £3,238.54 after this week's drop. Each penny change in share price is now worth £940. For such a volatile share this is going to be a hell of a roller coaster! My ambition is to get to 100,000 shares now I'm so close. I already own more than 0.1% of the company, which I never thought would happen.
IQE:IQE had a great week last week and I was hoping my ISA holding would get back into profit. However, this week it dropped 6% so the wait continues as they are now 17% down.
JLP:Jubilee Metals may be stirring for a re-rate. They are producing now and ramping up processing capacity, so I feel we're only one announcement away from getting back into profit. The climbed 6% this week but are still stuck on the range between 2.9p and 3.2p and are still 29% down.
Share of the week is TRMR:Tremor in the trading account. They have recently changed their name from TAP:Taptica and seem to be on the march. They climbed 10% this week, but had fallen so far that they are still 43% down.
In real terms this is the worst ever, as I've added so much into the SIPP this year. I'm really hoping patience will be rewarded.
Neil Woodford eat your heart out!
Here's the performance of the ISA and shares portfolios
| Weekly Change | |||
| Cash | £23.52 | -£3.84 | |
| Portfolio cost | £57,992.82 | +£35.19 | |
| Portfolio sell value (bid price-commission) | £45,028.13 | (-22.3%) | -£3.627.45 |
| Potential profits | £0 | -£2,233.44 | |
| Yr 4 Dividends | £103.97 | +£0 | |
| Yr 4 Profit from sales | £1,694.29 | +£35.10 | |
| Yr 4 Average monthly cash profit | £146.42 | (3.0%) | +£0.11 |
| Total Dividends | £1,342.30 | +£0 | |
| Total Profit from sales | £20,391.41 | +£35.10 | |
| Average monthly cash profit | £448.87 | (9.3%) | -£1.44 |
| (Sold stocks profit + Dividends - Fees / Months) |
I sold 1,198 shares in CEY:Centamin and made a tiny £35.10 (2.2%) profit, but with over £50 dividends the total profit was 6%. I used the proceeds to buy 2,312 shares in OPTI:Optibiotix at 67p a share which slightly raises my weighted average to 66.46p, but 67p is pretty much the average across the portfolio so I'm happy to get more at that price.
The sale had virtually no affect on my performance, and as we come to the final week of year 4 I've only achieved 3% on sales and dividends which is way below my 10% target. Under the circumstances, maintaining my long term performance at 9.3% over a 4 year period is pretty impressive, especially as that's based on the current portfolio cost which has increased a lot.
The bad news is the potential profits being completely wiped out to zero, and losses deepening a further £1,400 on top of that. Not a great week!
This is getting dangerously close to my initial cash injection line, which would mean I've made absolutely nothing in 4 years and would have been as well putting the cash in the building society.
The SIPP looks like this after week 192
| Weekly Change | |||
| Cash | £15.52 | -£115.58 | |
| Portfolio cost | £44,226.49 | +£2,993.50 | |
| Portfolio sell value (bid price - commission) | £37,902.15 | (-14.3%) | -£3,504.02 |
| Potential profits | £0 | -£1,562.49 | |
| Yr 4 Dividends | £361.99 | +£0 | |
| Yr 4 Interest | £0.09 | +£0 | |
| Yr 4 Profit from sales | £1,440.43 | +£696.83 | |
| Yr 4 Average monthly cash profit | £202.26 | (5.5%) | +£78.68 |
| Total Dividends | £1,704.24 | +£0 | |
| Total Interest | £0.12 | +£0 | |
| Total Profit from sales | £11,985.35 | +£696.83 | |
| Average monthly cash profit | £299.85 | (8.1%) | +£13.91 |
| (Sold stocks profit + Dividends - Fees / Months) |
I sold my 2,965 CEY:Centamin shares for £696.83 (23%) profit, and with the £68 of dividends that was 25%. I used the cash to buy 5,596 OPTI:Optibiotix shares at 66.66p costing £3,742.24. The day before I had my £2,200 pension transfer. I initially bought 393 shares in CAML:Central Asia Metals for 205.67p costing £820.23 which brought my total holding there to 5,000 shares. They are now 9.5% of my portfolio cost and I still consider them to be the best run company I own.
The rest of the transfer was used to buy OPTI:Optibiotix. I purchased 2,070 shares at 69.44p costing £1,449.36. My weighted average price in the SIPP is now 67.97p.
All potential profits were wiped out with the sale and OPTI crash, and losses deepened by an additional £2,000. The sale almost doubled my year 4 performance to 5.5%, but although my long term average improved by £13 a month, the cost of the portfolio rose enough for my percentage performance to drop from 8.3% to 8.1%. I sometimes think my rules are too strict!
Not familiar territory for this account.
I seem to have dropped off a cliff!
The trading portfolio looks like this after week 158
| Weekly Change | |||
| Cash | £35.04 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,374.40 | (-40.8%) | -£22.90 |
| Potential profits | £0 | +£0 | |
| Year 4 Dividends | £0 | +£0 | |
| Year 4 Profit | £0 | +£0 | |
| Yr 4 Average monthly cash profit | £0 | (0%) | +£0 |
| Dividends | £34.72 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£0.81 | (-0.4%) | +£0.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
The improvement in TRMR:Tremor mitigated the losses everywhere else so the drop was only £22.
Tootling along rubbishly
Still slowly dragging the trend line upwards
Here's the fantasy stock performance
I only dropped 25 places to 863rd so it could have been much worse.
CEY:Centamin doing very nicely so I'll keep the fantasy version. LLOY:Lloyds rather messing things up. I was hoping the end of PPI would cause a re-rate for the banks, but there are a few stngs in the PPI tail yet so I may have jumped too soon.
A week to forget for share prices, but a week of great excitement as I build my position in OPTI:Optibiotix. I'm still as certain as ever that this is a superb company with astonishing potential. It's brexit-proof and on the cusp of some staggering global deals. The share price was lower than this a year ago, and hit 130p within a few weeks. The rise from here to 130p would be worth £62,000 with my current holding. Bring it on!
Subscribe to:
Posts (Atom)